Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore Medical Dialogues Bureau20 Nov 2019 4:00 AM GMTSuven Life Sciences provides contract research and manufacturing services to global life sciences companies. It plans to invest 75 million dollars...
Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US Medical Dialogues Bureau13 Nov 2019 4:03 AM GMT"The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma Medical Dialogues Bureau2 Nov 2019 3:45 AM GMTConsolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last...
Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates Medical Dialogues Bureau30 Oct 2019 4:00 AM GMTPfizer said it expects to earn between $2.94 per share and $3.00 per share, up from a prior estimate of $2.76 to $2.86. Analysts on average were...
Cipla plans to file over dozen new drug applications for FY20 Garima27 May 2019 4:00 AM GMTIn another key market of South Africa, during the current fiscal year, Cipla is looking to strengthen its OTC (over-the-counter) business.New Delhi:...
Torrent Pharma posts Q4 net loss of Rs 152 crore Garima24 May 2019 3:45 AM GMTThe company had posted a net profit of Rs 228 crore for the corresponding period of the previous fiscal, Torrent Pharma said in a filing to the...
GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore Garima21 May 2019 4:00 AM GMTThe company had posted a net profit of Rs 105.55 crore for the corresponding period of the previous fiscal, GSK said in a filing to the BSE.New Delhi:...
Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4 Garima19 May 2019 4:00 AM GMTJubilant Life Sciences said its bottom line in the quarter was hit by a one-time loan settlement with IFC, that resulted in an exceptional item of Rs...
Granules India Q1 net profit up 41 percent to Rs 51.7 crore Ruby Khatun Khatun25 July 2018 4:30 AM GMTNew Delhi: Drug firm Granules India reported a 40.73 percent rise in its consolidated net profit at Rs 51.79 crore for the quarter ended on June 30,...
Sanofi dengue vaccine may worsen disease, company takes 120 million dollars hit Ruby Khatun Khatun30 Nov 2017 8:39 AM GMTPARIS: Use of Sanofi's dengue vaccine, the world's first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it...
Cadila Healthcare Q2 net profit up 32 percent at Rs 503 crore Ruby Khatun Khatun15 Nov 2017 4:30 AM GMTNew Delhi: Drug firm Cadila Healthcare reported a 32.48 percent rise in its consolidated net profit to Rs 503.3 crore for the second quarter ended...
Apollo Hospitals Q2 net dips 23 percent to Rs 71 crore Ruby Khatun Khatun15 Nov 2017 3:56 AM GMTNew Delhi: Apollo Hospitals Enterprise reported 22.92 percent dip in standalone net profit to Rs 70.90 crore for the September quarter of the current...